Regulation of human immunodeficiency virus type 1 replication in human T lymphocytes by nitric oxide

Journal of Virology
J L JiménezM A Muñoz-Fernández

Abstract

Addition of nitric oxide (NO) donors to mitogen-activated human immunodeficiency virus type 1 (HIV-1)-infected peripheral blood mononuclear cultures produced a significant increase in virus replication, and this effect was not associated with a change in cell proliferation. This effect was only observed with T-tropic X4 or X4R5 virus but not with R5 virus. Moreover, HIV-1 replication in mitogen-stimulated cultures was partially prevented by the specific inhibitors of the inducible nitric oxide synthase (iNOS). NO donors also enhanced HIV-1 infection of the human T-cell lines, Jurkat and MT-2. We have also observed that NO leads to an enhancement of HIV-1 replication in resting human T cells transfected with a plasmid carrying the entire HIV-1 genome and activated with phorbol ester plus ionomycin. Thus, in those cultures NO donors strongly potentiated HIV-1 replication in a dose-dependent manner, up to levels comparable to those with tumor necrosis factor alpha (TNF-alpha) stimulation. Furthermore, iNOS inhibitors decreased HIV-1 replication in HIV-1-transfected T cells to levels similar to those obtained with neutralizing anti-TNF-alpha antibodies. Moreover, HIV-1 replication induced iNOS and TNF-alpha transcription in T cells...Continue Reading

References

Mar 1, 1994·The Biochemical Journal·R G Knowles, S Moncada
Sep 23, 1994·Cell·C Nathan, Q W Xie
Jan 1, 1994·Annual Review of Biochemistry·D S Bredt, S H Snyder
Jul 1, 1995·Clinical Immunology and Immunopathology·A O Vladutiu
Jun 1, 1995·Current Opinion in Immunology·F Y Liew
Jun 1, 1995·Annals of Medicine·E Moilanen, H Vapaatalo
Sep 8, 1995·The Journal of Biological Chemistry·H M LanderA Novogrodsky
Mar 1, 1995·Trends in Microbiology·K L Powell, S A Baylis
Jun 9, 1995·The Journal of Biological Chemistry·H B PengJ K Liao
May 1, 1994·International Journal of Immunopharmacology·D EmilieP Galanaud
Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·V L DawsonS H Snyder
Jan 1, 1995·Advances in Pharmacology·U FörstermannN J Dun
Mar 19, 1996·Proceedings of the National Academy of Sciences of the United States of America·K ForresterC C Harris
Jul 5, 1996·Biochemical and Biophysical Research Communications·H RotheH Kolb
Aug 16, 1996·The Journal of Biological Chemistry·H M LanderJ M Tauras
Jan 1, 1996·Antibiotics and Chemotherapy·A S Fauci
Nov 1, 1995·Research in Immunology·J B Mannick
Oct 1, 1996·The Biochemical Journal·U K Messmer, B Brüne
Nov 1, 1996·Medical Hypotheses·D Torre, G Ferrario
Jan 1, 1997·Annual Review of Immunology·J MacMickingC Nathan
Sep 12, 1997·The Journal of Biological Chemistry·C ScioratiE Clementi
Jan 7, 1998·Immunological Reviews·O J CohenA S Fauci
Feb 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·R J DuhéW L Farrar
Apr 4, 1998·The Journal of Experimental Medicine·C HierholzerD J Tweardy
Jun 6, 1998·The Journal of Experimental Medicine·C Bogdan
Jul 1, 1997·International Journal of Immunopharmacology·E HermannG M Bahr
Jul 8, 1999·The American Journal of Pathology·F ChenL M Demers

❮ Previous
Next ❯

Citations

Dec 3, 2002·Veterinary Immunology and Immunopathology·Kevin A KeaneJames C DeMartini
Mar 5, 2003·The Lancet Infectious Diseases·Elena ChiappiniMaurizio de Martino
Sep 29, 2001·Nature Immunology·C Bogdan
Jun 14, 2002·The Lancet Infectious Diseases·Donato TorreFilippo Speranza
Oct 28, 2008·Nitric Oxide : Biology and Chemistry·Yuzo FujikuraZora Melkova
Jan 9, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Ernesto CairoliAlfonso Cayota
Apr 6, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Renata Mezomo SoccalJosé Edson Paz da Silva
Aug 30, 2012·Hemodialysis International·Marlene S B GonçalvesDécio S Barbosa
Feb 16, 2005·Brain Research. Molecular Brain Research·Chava B PocernichD Allan Butterfield
Jul 26, 2015·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Elaine Uchima UeharaCyro Alves de Brito
Feb 26, 2009·FEMS Immunology and Medical Microbiology·Umesh C Chaturvedi, Rachna Nagar
Oct 7, 2016·Folia Microbiologica·Zora MelkovaJosef Bodor
Nov 11, 2016·Oxidative Medicine and Cellular Longevity·Alexander V IvanovMaria G Isaguliants
Jul 31, 2002·BMC Infectious Diseases·Ajay WanchuSurjit Singh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.